PepGen Inc. Q1 2025 10-Q Filing
Ticker: PEPG · Form: 10-Q · Filed: May 8, 2025 · CIK: 1835597
| Field | Detail |
|---|---|
| Company | Pepgen Inc. (PEPG) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, R&D, stock-offering
TL;DR
PepGen's Q1 2025 10-Q is in. Check R&D and G&A spend.
AI Summary
PepGen Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial activities, including research and development expenses and general and administrative expenses for the first quarter of 2025. Key events mentioned include a Shares Sales Agreement and Follow-On Offering in February 2024, and details regarding common stock and restricted stock units as of March 31, 2025.
Why It Matters
This filing provides insight into PepGen's financial health and operational activities during the first quarter of 2025, which can influence investor decisions.
Risk Assessment
Risk Level: medium — The filing details financial performance and operational activities, which are crucial for assessing the company's risk profile.
Key Numbers
- Q1 2025 — Reporting Period (Financial activities for the first quarter of 2025 are detailed.)
- March 31, 2025 — As of Date (Key balance sheet information is presented as of this date.)
- February 2024 — Key Event Date (Significant financing events like the Shares Sales Agreement and Follow-On Offering occurred.)
Key Players & Entities
- PepGen Inc. (company) — Filer
- 20250331 (date) — Period of Report
- 20250508 (date) — Filed as of Date
- 0000950170-25-066414 (other) — Accession Number
- 2834 (other) — Standard Industrial Classification Code
- 001-41374 (other) — SEC File Number
- 2024-02-09 (date) — Shares Sales Agreement and Follow-On Offering Date
- 2024-02-05 (date) — Shares Sales Agreement Date
FAQ
What were PepGen Inc.'s Research and Development expenses for the first quarter of 2025?
The filing indicates that Research and Development expenses were reported for the period of January 1, 2025, to March 31, 2025.
What is the company's fiscal year end?
PepGen Inc.'s fiscal year ends on December 31.
When did the Shares Sales Agreement and Follow-On Offering occur?
The Shares Sales Agreement and Follow-On Offering is noted with a date of February 9, 2024.
What is PepGen Inc.'s business address?
PepGen Inc.'s business address is 1 Marina Park Drive, Suite 900, Boston, MA 02210.
What type of stock is mentioned in relation to the IPO?
The filing mentions 'us-gaap:CommonStockMember' in relation to the IPO for the period of January 1, 2024, to March 31, 2024.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding PepGen Inc. (PEPG).